Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;7(3):458-460.
doi: 10.1001/jamaoncol.2020.7600.

Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic

Affiliations

Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic

Ziad Bakouny et al. JAMA Oncol. .

Abstract

This cohort study describes the number of patients undergoing cancer screening tests and of ensuing cancer diagnoses during the COVID-19 pandemic in 1 health care system in the northeastern United States.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Bakouny reported receiving grants from Genentech/IMCore and nonfinancial support from Bristol Myers Squibb outside the submitted work. Dr Schmidt reported receiving nonfinancial support from Astellas and Pfizer outside the submitted work. Dr Choueiri reported receiving nonfinancial support from the COVID-19 and Cancer Consortium during the conduct of the study and personal fees from Pfizer, Exelixis, Bristol Myers Squibb, Merck, Roche/Genentech, and Novartis related to kidney cancer for clinical trials, to being on advisory boards, to consultancy, and to manuscript support outside the submitted work. Dr Trinh reported receiving personal fees from Astellas, Bayer, and Janssen and grants from Intuitive Surgical outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Changes in the Numbers of Cancer Screening Tests and Ensuing Diagnoses
Changes in the numbers of cancer screening tests and ensuing diagnoses by cancer screening test and screening period during the primary pandemic study period compared with 3 control periods (subsequent 3 months, preceding 3 months, and same 3 months in the preceding year). CT indicates computed tomography; PSA, prostate-specific antigen.
Figure 2.
Figure 2.. Percentage Decreases in the Numbers of Screening Tests and Ensuing Diagnoses
Percentage decreases during the primary pandemic study period compared with 3 control periods (subsequent 3 months, preceding 3 months, and same 3 months in the preceding year) in the number of screening tests (A) and in the number of screening tests leading to diagnoses of cancerous or precancerous lesions (B). Error bars indicate 95% CIs. CT indicates computed tomography; PSA, prostate-specific antigen.

References

    1. Mass.gov. Archive of COVID-19 cases in Massachusetts. Accessed October 25, 2020. https://www.mass.gov/info-details/archive-of-covid-19-cases-in-massachus...

Publication types

Substances